Carregant...
Progress in the Management of Limited-Stage Small Cell Lung Cancer
About 15% of lung cancer cases are of the small cell subtype, but this variant is highly aggressive and often diagnosed at advanced stages. Outcomes after current treatment regimens have been poor, with 5-year survival rates as low as 25% for patients with limited-stage disease. Advances in therapy...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3947683/ https://ncbi.nlm.nih.gov/pubmed/24327434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28505 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|